Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis.
Naoi H, Suzuki Y, Mori K, Aono Y, Kono M, Hasegawa H, Yokomura K, Inoue Y, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Suda T. Naoi H, et al. Among authors: karayama m. Thorax. 2022 Jul;77(7):727-730. doi: 10.1136/thoraxjnl-2021-218281. Epub 2022 Mar 30. Thorax. 2022. PMID: 35354649
Antiendothelial Cell Antibodies in Patients With COPD.
Karayama M, Inui N, Suda T, Nakamura Y, Nakamura H, Chida K. Karayama M, et al. Chest. 2010 Dec;138(6):1303-8. doi: 10.1378/chest.10-0863. Epub 2010 Jun 24. Chest. 2010. PMID: 20576735
Nonspecific interstitial pneumonia: prognostic significance of high-resolution computed tomography in 59 patients.
Hozumi H, Nakamura Y, Johkoh T, Sumikawa H, Colby TV, Karayama M, Hayakawa H, Yokomura K, Imokawa S, Yasuda K, Toyoshima M, Suganuma H, Shirai T, Inui N, Suda T, Nakamura H, Chida K. Hozumi H, et al. Among authors: karayama m. J Comput Assist Tomogr. 2011 Sep-Oct;35(5):583-9. doi: 10.1097/RCT.0b013e31822a5883. J Comput Assist Tomogr. 2011. PMID: 21926853
Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: a randomized, phase-II study.
Kusagaya H, Inui N, Karayama M, Nakamura Y, Kuroishi S, Yokomura K, Toyoshima M, Shirai T, Masuda M, Yamada T, Yasuda K, Suda T, Chida K. Kusagaya H, et al. Among authors: karayama m. Lung Cancer. 2012 Sep;77(3):550-5. doi: 10.1016/j.lungcan.2012.05.106. Epub 2012 Jun 15. Lung Cancer. 2012. PMID: 22705118 Clinical Trial.
Maintenance therapy with pemetrexed versus docetaxel after induction therapy with carboplatin and pemetrexed in chemotherapy-naïve patients with advanced non-squamous non-small-cell lung cancer: a randomized, phase II study.
Karayama M, Inui N, Kuroishi S, Yokomura K, Toyoshima M, Shirai T, Masuda M, Yamada T, Yasuda K, Suda T, Chida K. Karayama M, et al. Cancer Chemother Pharmacol. 2013 Aug;72(2):445-52. doi: 10.1007/s00280-013-2218-6. Epub 2013 Jun 27. Cancer Chemother Pharmacol. 2013. PMID: 23807323 Clinical Trial.
Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations.
Inoue Y, Inui N, Asada K, Karayama M, Matsuda H, Yokomura K, Koshimizu N, Imokawa S, Yamada T, Shirai T, Kasamatsu N, Suda T. Inoue Y, et al. Among authors: karayama m. Cancer Chemother Pharmacol. 2015 Jul;76(1):155-61. doi: 10.1007/s00280-015-2784-x. Epub 2015 May 24. Cancer Chemother Pharmacol. 2015. PMID: 26003540 Clinical Trial.
162 results